Laboratory test abnormalities are common in polymyositis and dermatomyositis and differ among clinical and demographic groups

Open Rheumatology Journal

Volumn 6, Issue 1, 2012, Pages 54-63

  Volochayev, Rita ^a   Csako, Gyorgy ^b   Wesley, Robert ^b   Rider, Lisa G ^a   Miller, Frederick W ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Laboratory testing; Myositis; Phenotypes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATINE KINASE MB; FRUCTOSE BISPHOSPHATE ALDOLASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; MYOGLOBIN;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOCRIT; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; POLYMYOSITIS; PRIORITY JOURNAL; RACE DIFFERENCE; REFERENCE VALUE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYNDROME DELINEATION;

EID: 84861842144     PISSN: None     EISSN: 18743129     Source Type: Journal    
DOI: 10.2174/1874312901206010054     Document Type: Article

References (28)

1. Miller FW. Inflammatory Myopathies: Polymyositis, dermato-myositis, and related conditions. In: Arthritis and Allied Conditions. W. Koopman and L. Moreland Lippincott Eds. A Textbook of Rheumatology. Philadelphia: Williams and Wilkins 2005: pp 1593-1620.
2. Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. J Am Med Assoc 2011; 305(2): 183-190.
3. Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003; 27(4): 407-425.
4. Munsat TL, Baloh R, Pearson CM, Fowler WJ. Serum enzyme alterations in neuromuscular disorders. J Am Med Assoc 1973; 226: 1536-1543.
5. Rider LG, Miller FW. Laboratory evaluation of the inflammatory myopathies. Clin Diagn Lab Immunol 1995; 2(1): 1-9.
6. Bohlmeyer TJ, Wu AH, Perryman MB. Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis. Rheum Dis Clin North Am 1994; 20: 845-856.
7. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977; 56: 255-286.
8. Miller FW. Polymyositis and Dermatomyositis. In: L Goldman and D Ausiello Eds. Cecil Textbook of Medicine. Philadelphia: Saunders 2004; pp. 1680-1684.
9. Bohan A, Peter JB. Polymyositis and dermatomyositis. Parts 1 and 2. N Engl J Med 1975; 292: 344-347.
10. Hinkle DE, Wiersma W, Jurs SG. Applied statistics for behavioral sciences. Chicago: Rand McNally 1979.
11. Diessner GR, Howard FM Jr, Winkelmann RK, Lambert EH, Mulder DW. Laboratory tests in polymyositis. Arch Intern Med 1966; 117: 757-763.
12. Viguier M, Fouere S, de la Salmoniere P, et al. Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine 2003; 82(2): 82-86.
13. Harris EK, Wong ET, Shaw ST. Statistical criteria for separate reference intervals: race and gender groups in creatine kinase. Clin Chem 1991; 39: 1580-1582.
14. Stranges S, Dorn JM, Muti P, et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 2004; 39(3): 754-763.
15. Ama PF, Simoneau JA, Boulay MR, Serresse O, Theriault G, Bouchard C. Skeletal muscle characteristics in sedentary black and Caucasian males. J Appl Physiol 1986; 61(5): 1758-1761.
16. Saxena S, Wong ET. Heterogeneity of common hematologic parameters among racial, ethnic, and gender subgroups. Arch Pathol Lab Med 1990; 114(7): 715-719.
17. Gillum RF. A racial difference in erythrocyte sedimentation. J Natl Med Assoc 1993; 85(1): 47-50.
18. Yip R, Johnson C, Dallman PR. Age-related changes in laboratory values used in the diagnosis of anemia and iron deficiency. Am J Clin Nutr 1984; 39(3): 427-436.
19. Kagen LJ, Aram S. Creatine kinase activity inhibitor in sera from patients with muscle disease. Arthritis Rheum 1987; 30: 213-217.
20. Warren GL, O'farrell L, Rogers KR, Billings KM, Sayers SP, Clarkson PM. CK-MM autoantibodies: prevalence, immune complexes, and effect on CK clearance. Muscle Nerve 2006; 34(3): 335-346.
21. Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002; 28(4): 859-890.
22. International Committee for Standardization in Hematology. Recommendation for measurement of erythrocyte sedimentation rate of human blood. Am J Clin Pathol 1977; 68: 505-507.
23. Black HR, Quallich H, Gareleck CB. Racial differences in serum creatine kinase levels. Am J Med 1986; 81: 479-487.
24. Arenas J, Diaz V, Liras G, et al. Activities of creatine kinase and its isoenzymes in serum in various skeletal muscle disorders. Clin Chem 1988; 34: 2460-2462.
25. Apple FS. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. Clin Chim Acta 1999; 284(2): 151-159.
26. Meighan MRL, Tolan DR. Noncoordinate changes in the steady-state mRNA expressed from aldolase A and aldolase C genes during differentiation of chicken myoblasts. J Cell Biochem 1995; 57(3): 423-431.
27. Barjot C, Laplace MV, Gannoun ZL, et al. Expression of lactate dehydrogenase, myosin heavy chain and myogenic regulatory factor genes in rabbit embryonic muscle cell cultures. J Muscle Res Cell Motil 1998; 19(4): 343-351.
28. Loike JD, Kozler VF, Silverstein SC. Creatine kinase expression and creatine phosphate accumulation are developmentally regulated during differentiation of mouse and human monocytes. J Exp Med 1984; 159(3): 746-757.